Werewolf Therapeutics (HOWL) Accumulated Depreciation & Amortization (2021 - 2024)
Werewolf Therapeutics (HOWL) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $5.0 million as the latest value for Q4 2024.
- On a quarterly basis, Accumulated Depreciation & Amortization rose 57.22% to $5.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.0 million, a 57.22% increase, with the full-year FY2024 number at $5.0 million, up 57.22% from a year prior.
- Accumulated Depreciation & Amortization was $5.0 million for Q4 2024 at Werewolf Therapeutics, up from $3.2 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.0 million in Q4 2024 to a low of $391000.0 in Q4 2021.
- A 4-year average of $2.5 million and a median of $2.3 million in 2022 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 259.59% in 2022, then skyrocketed 57.22% in 2024.
- Werewolf Therapeutics' Accumulated Depreciation & Amortization stood at $391000.0 in 2021, then surged by 259.59% to $1.4 million in 2022, then skyrocketed by 125.46% to $3.2 million in 2023, then soared by 57.22% to $5.0 million in 2024.
- Per Business Quant, the three most recent readings for HOWL's Accumulated Depreciation & Amortization are $5.0 million (Q4 2024), $3.2 million (Q4 2023), and $1.4 million (Q4 2022).